Wednesday, September 15th – 12:30 PM EST
Digital Event: |
Overview:
Join Thomas Busby, Vice President at Outcome Capital, for a discussion on creating safe, usable medical device solutions– from the early prototyping phase to proof-of-concept. For more information, please contact |
Macroeconomic uncertainty, confusion surrounding the diagnostic regulatory landscape, and the continuing post-COVID-19 pandemic hangover have all contributed to a stagnant, quiet period for mergers and acquisitions in the in vitro diagnostics space in the first half of 2024.
Read MoreOutcome Capital Life Science Market Pulse June 2024 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?